Blue Light Exposure During Sleep in Type 1 Diabetes: Impacts on Glycemic Control and Psychosocial Health.
J Sleep ResJun 5, 2026 (epub)
Seok Jin Hong, Sarida Pratuangtham, Pamela Martyn-Nemeth et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial examined the effects of blue and white light exposure during sleep on glycemic control and psychosocial health in 170 adults with type 1 diabetes. The study found that greater blue light exposure was significantly associated with higher glucose levels, including a decrease in time spent in the target glucose range (B = -7.30; p = 0.022) and increased depressive symptoms (B = 4.41; p = 0.016).
Key findings
- Greater blue light exposure was associated with a decrease in % time spent in glucose range 70-180 mg/dL (B = -7.30; p = 0.022).
- Increased blue light exposure correlated with greater % time spent above glucose range 180 mg/dL (B = 6.95; p = 0.041).
- Higher blue light exposure was linked to increased depressive symptoms (B = 4.41; p = 0.016) and anxiety symptoms (B = 2.25; p = 0.008).
- Light exposure one hour prior to sleep was related to increased fatigue.
Why it matters
Understanding the impact of nighttime light exposure on glycemic control and mental health is crucial for managing type 1 diabetes. This study highlights a potential modifiable risk factor that could improve patient outcomes.